NATCO Pharma Limited (BOM:524816)
India · Delayed Price · Currency is INR 919.85
-10.85 (-1.17%)
At close: Jul 31, 2026
NATCO Pharma Market Cap
NATCO Pharma has a market cap or net worth of 164.24 billion as of July 31, 2026. Its market cap has decreased by -5.77% in one year.
Market Cap
164.24B
Enterprise Value
150.09B
Revenue
40.78B
Ranking
n/a
PE Ratio
11.58
Stock Price
919.85
ChartMarket Cap Chart
Since March 31, 1999, NATCO Pharma's market cap has increased from 429.39M to 164.24B, an increase of 38,150.61%. That is a compound annual growth rate of 24.28%.
| Date | Market Cap | % Change |
|---|---|---|
| Jul 31, 2026 | 164.24B | 1.54% |
| Dec 31, 2025 | 161.75B | -34.91% |
| Dec 31, 2024 | 248.48B | 70.99% |
| Dec 29, 2023 | 145.32B | 41.73% |
| Dec 30, 2022 | 102.53B | -37.85% |
| Dec 31, 2021 | 164.98B | -5.86% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| J. B. Chemicals & Pharmaceuticals | 387.31B |
| Rubicon Research | 245.64B |
| Granules India | 206.66B |
| AstraZeneca Pharma India | 202.59B |
| Caplin Point Laboratories | 191.15B |
| Jubilant Pharmova | 148.07B |
| CORONA Remedies | 127.89B |
| Viyash Scientific | 110.01B |